News

All News

Your Guide to Understanding USP General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing and Repackaging

Radiopharmaceuticals represent a unique class of drug products where compounding and other handling activities include the use of radionuclide generators, the preparation of commercially manufactured radiopharmaceutical kits, the dilution of FDA-approved multi-dose vials, the labeling of human blood products with radionuclides, the preparation of patient-specific radiopharmaceutical doses and more. These […]

April 9, 2024
Read More

RLS Radiopharmacies Partners with Eckert & Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

RLS expands rCDMO capabilities with Eckert & Ziegler’s GalliaPharm® generators for improved patient diagnostics LAKE MARY, FL & BERLIN, GERMANY – April 4, 2024 —RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacynetwork, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement […]

April 4, 2024
Read More

The Vital Partnership Between Radiopharmaceutical Developers and Radiopharmacies

Radiopharmaceuticals represent a burgeoning frontier in modern medicine, ushering in a new era of diagnostic and therapeutic potential powered by the principles of nuclear science. While the medical application of radiation dates back over a century, the recent advancements and increasing interest in radiopharmaceuticals have marked the beginning of a […]

April 4, 2024
Read More

AtomVie Global Radiopharma Collaborates with RLS & UPPI to Strengthen its Existing U.S. Radiotherapeutic Distribution Network

HAMILTON, ON and LAKE MARY, FL – February 22, 2024 – AtomVie Global Radiopharma Inc. (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is proud to announce strategic collaborations with RLS Radiopharmacies and UPPI LLC. (UPPI), two industry leaders in radiopharmacy and logistics. This strategic move is poised […]

February 23, 2024
Read More

RLS Expands by Offering Radiopharmaceutical Contract Development and Manufacturing (rCDMO) Services

The nation’s only Joint Commission-accredited radiopharmacy network is bringing life-saving nuclear medicines closer to patients RLS Radiopharmacies, the only Joint Commission-accredited radiopharmacy network in the U.S., announced it is expanding its business operations with the addition of radiopharmaceutical contract development and manufacturing (rCDMO) services. The new offering will enable RLS […]

October 26, 2023
Read More

What the Radiopharmaceutical Pipeline Means for Patient Care

With increased access to cutting-edge imaging, improved treatment options, greater personalization of treatment, reduced radiation exposure, and potential for future advances, patients can expect to receive more advanced medical care tailored to their specific needs through radiopharmaceuticals. The healthcare field has radically transformed thanks to scientific innovations and technological advancements. […]

October 16, 2023
Read More

The Supply and Availability of Radiopharmaceuticals

These medical isotope-fueled compounds are being used for the diagnosis and treatment of cancer, neurological disorders, and cardiovascular disease.

August 25, 2023
Read More

RADIOPHARMACY NETWORK RLS ANNOUNCES EXECUTIVE APPOINTMENTS IN SALES AND HUMAN RESOURCES

Recent Hires Come as Leading Nuclear Pharmacy Network Continues to Expand Capabilities, Enter New Markets and Partner with Industry Pioneers

June 22, 2023
Read More

RLS AND SOFIE ENTER STRATEGIC PARTNERSHIP FOR DISTRIBUTION OF NUCLEAR MEDICINE DOSES FOR PATIENTS

SOFIE to Manufacture Batches, RLS to Compound and Distribute to SOFIE Customers, Improving Continuum of Care for Patients

June 21, 2023
Read More

RLS APPOINTS GLENN SULLIVAN AS DIRECTOR OF REGULATORY AFFAIRS

New Appointment Marks Latest in RLS’s Commitment to Best-in-Class Regulation as Radiopharmacy Network Continues to Scale for Long-Term Growth

June 13, 2023
Read More

Connect With Us

We’re here to help. If you have an order or account related question or concern, please contact your RLS Account Manager directly or call your local RLS Radiopharmacy at 800 242 8004.

For additional inquiries, please visit our contact page and select from the list below:
General, Business Support, Careers, Media

connect with us